Brainstorming Session on Drug Regulatory Reforms in India-1st March 2016
Tuesday, 1st March 2016
New Delhi 110003

In the second year of its research program on Drug Regulatory Reforms in India, ICRIER’s Health Policy Initiative organized a Brainstorming Session on 1 March, 2016. The main purpose of this Session was to elicit views of a select group of eminent experts and stakeholders to guide our research papers in the year 2016 – Harmonization of Drug Registration Procedures: An Impact Assessment for India, and Clinical Trials: Prospects and Challenges in India. The event commenced with welcome remarks by Prof. Anwarul Hoda, Chair Professor, ICRIER, which were followed by short presentations on each research paper. Afterwards, a round of questions, comments and suggestions on the presentations by various experts took place.

 

Distinguished experts who participated proactively in the discussion include Ms Leena Menghaney Regional Head, MSF; Dr Y K Gupta, Professor and Head, AIIMS; Prof B E Bierer, Professor, Harvard University; Mr. BejonMisra, Founder, Consumer Online Foundation; Mr D G Shah, Secretary General, Indian Pharmaceutical Alliance, among others.

FacebookTwitterGoogle+Share